Overview

Midodrine Use in Septic Shock

Status:
Unknown status

Trial end date:
2020-05-30

Target enrollment:

Participant gender:

Summary

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

Phase:

Phase 3

Details

Lead Sponsor:

University of Virginia

Treatments:

Midodrine